373 related articles for article (PubMed ID: 12525840)
21. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
22. Homogeneity and long-term stability of tetracycline-regulated gene expression with low basal activity by using the rtTA2S-M2 transactivator and insulator-flanked reporter vectors.
Qu Z; Thottassery JV; Van Ginkel S; Manuvakhova M; Westbrook L; Roland-Lazenby C; Hays S; Kern FG
Gene; 2004 Feb; 327(1):61-73. PubMed ID: 14960361
[TBL] [Abstract][Full Text] [Related]
23. A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression.
Rubinchik S; Wang D; Yu H; Fan F; Luo M; Norris JS; Dong JY
Mol Ther; 2001 Nov; 4(5):416-26. PubMed ID: 11708878
[TBL] [Abstract][Full Text] [Related]
24. Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain.
Paterna JC; Moccetti T; Mura A; Feldon J; Büeler H
Gene Ther; 2000 Aug; 7(15):1304-11. PubMed ID: 10918501
[TBL] [Abstract][Full Text] [Related]
25. Tetracycline-inducible expression systems for the generation of transgenic animals: a comparison of various inducible systems carried in a single vector.
Bäckman CM; Zhang Y; Hoffer BJ; Tomac AC
J Neurosci Methods; 2004 Oct; 139(2):257-62. PubMed ID: 15488239
[TBL] [Abstract][Full Text] [Related]
26. Controlled transgene expression by E1-E4-defective adenovirus vectors harbouring a "tet-on" switch system.
Fender P; Jeanson L; Ivanov MA; Colin P; Mallet J; Dedieu JF; Latta-Mahieu M
J Gene Med; 2002; 4(6):668-75. PubMed ID: 12439858
[TBL] [Abstract][Full Text] [Related]
27. A tetracycline-regulatable adeno-associated virus vector for double-gene transfer.
Wang JJ; Niu DB; Zhang T; Wang K; Xue B; Wang XM
Neurosci Lett; 2005 Apr; 378(2):106-10. PubMed ID: 15774267
[TBL] [Abstract][Full Text] [Related]
28. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
[TBL] [Abstract][Full Text] [Related]
29. Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo.
Koponen JK; Kankkonen H; Kannasto J; Wirth T; Hillen W; Bujard H; Ylä-Herttuala S
Gene Ther; 2003 Mar; 10(6):459-66. PubMed ID: 12621450
[TBL] [Abstract][Full Text] [Related]
30. Second-generation tetracycline-regulatable promoter: repositioned tet operator elements optimize transactivator synergy while shorter minimal promoter offers tight basal leakiness.
Agha-Mohammadi S; O'Malley M; Etemad A; Wang Z; Xiao X; Lotze MT
J Gene Med; 2004 Jul; 6(7):817-28. PubMed ID: 15241789
[TBL] [Abstract][Full Text] [Related]
31. A novel doxycycline inducible autoregulatory plasmid which displays "on"/"off" regulation suited to gene therapy applications.
Gould DJ; Berenstein M; Dreja H; Ledda F; Podhajcer OL; Chernajovsky Y
Gene Ther; 2000 Dec; 7(24):2061-70. PubMed ID: 11223986
[TBL] [Abstract][Full Text] [Related]
32. Comparison of promoter strengths on gene delivery into mammalian brain cells using AAV vectors.
Doll RF; Crandall JE; Dyer CA; Aucoin JM; Smith FI
Gene Ther; 1996 May; 3(5):437-47. PubMed ID: 9156805
[TBL] [Abstract][Full Text] [Related]
33. Adenoviral vector which delivers FasL-GFP fusion protein regulated by the tet-inducible expression system.
Rubinchik S; Ding R; Qiu AJ; Zhang F; Dong J
Gene Ther; 2000 May; 7(10):875-85. PubMed ID: 10845726
[TBL] [Abstract][Full Text] [Related]
34. Tetracycline-regulated bone morphogenetic protein 2 gene expression in lentivirally transduced primary rabbit chondrocytes for treatment of cartilage defects.
Wübbenhorst D; Dumler K; Wagner B; Wexel G; Imhoff A; Gansbacher B; Vogt S; Anton M
Arthritis Rheum; 2010 Jul; 62(7):2037-46. PubMed ID: 20309869
[TBL] [Abstract][Full Text] [Related]
35. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells.
Fechner H; Wang X; Wang H; Jansen A; Pauschinger M; Scherübl H; Bergelson JM; Schultheiss HP; Poller W
Gene Ther; 2000 Nov; 7(22):1954-68. PubMed ID: 11127584
[TBL] [Abstract][Full Text] [Related]
36. Inducible and reversible transgene expression in human stem cells after efficient and stable gene transfer.
Zhou BY; Ye Z; Chen G; Gao ZP; Zhang YA; Cheng L
Stem Cells; 2007 Mar; 25(3):779-89. PubMed ID: 17158240
[TBL] [Abstract][Full Text] [Related]
37. The function of inducible promoter systems in F9 embryonal carcinoma cells.
Miller K; Rizzino A
Exp Cell Res; 1995 May; 218(1):144-50. PubMed ID: 7737354
[TBL] [Abstract][Full Text] [Related]
38. Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory system.
A-Mohammadi S; Hawkins RE
Gene Ther; 1998 Jan; 5(1):76-84. PubMed ID: 9536267
[TBL] [Abstract][Full Text] [Related]
39. Design and in vivo characterization of self-inactivating human and non-human lentiviral expression vectors engineered for streptogramin-adjustable transgene expression.
Mitta B; Weber CC; Rimann M; Fussenegger M
Nucleic Acids Res; 2004 Jul; 32(12):e106. PubMed ID: 15258250
[TBL] [Abstract][Full Text] [Related]
40. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
Su H; Huang Y; Takagawa J; Barcena A; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW
Gene Ther; 2006 Nov; 13(21):1495-502. PubMed ID: 16775632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
